STIMULUX

TM

Bringing Adaptive Stimulation to Light

Wavegate's patented StimuLux TM technology uses optical reflectometry to provide real-time adaptive spinal cord stimulation,  thereby optimizing therapy outcomes by maintaining consistent dosing.

TECHNOLOGY

INTELLECTUAL PROPERTY

StimuLux TM technology is based upon a broad portfolio of intellectual property covered by patents in the United States, European Union, Canada, Japan, and Australia.  Additional US patents pending.  StimuLux TM is a trademark of Wavegate Corporation.

HOW STIMULUX TM TECHNOLOGY WORKS

Optical Reflectometry

StimuLux TM technology integrates optoelectronic components and optical fiber into spinal cord stimulation systems to measure distance between the spinal cord and the epidural electrode array.  This allows real-time stimulus modulation to ensure consistent and efficacious adaptive stimulation with conventional and paresthesia-free stimulation paradigms.

 
 
Contact Us

Follow us on:

©2020 by Wavegate Corporation.

StimuLux (TM) Technology is covered under Patents 8,239,038; 8,543,213; 9,132,273; 9,550,063; 9,656,097; 9,821,161; 10,035,019; AU2015203820; EP2627399; AU2011314383; CA2814477; WO2012050619.  Additional patents pending.